United Therapeutics Corp (UTHR)
305.57
-1.52
(-0.49%)
USD |
NASDAQ |
Mar 13, 16:00
305.57
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Max Drawdown (5Y): 57.90% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| Madrigal Pharmaceuticals Inc | 82.20% |
| Biomarin Pharmaceutical Inc | 53.26% |
| Geron Corp | 86.09% |
| Regeneron Pharmaceuticals Inc | 44.76% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 13.78 |
| Beta (5Y) | 0.6384 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 32.44% |
| Historical Sharpe Ratio (5Y) | 0.7064 |
| Historical Sortino (5Y) | 1.862 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 9.99% |